Aligos Therapeutics, Inc. (ALGS) vs Actinium Pharmaceuticals, Inc. (ATNM)
- Aligos Therapeutics, Inc. ALGS 4.86 −9.83%
- Actinium Pharmaceuticals, Inc. ATNM 1.13 +6.60%
Aligos Therapeutics, Inc. and Actinium Pharmaceuticals, Inc. are both Biotechnology companies. Aligos Therapeutics, Inc. and Actinium Pharmaceuticals, Inc. are of similar size ($33.7M and $33.3M). Aligos Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Actinium Pharmaceuticals, Inc. trades at 3.1×. Actinium Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 2,731.2% against 893.0%. Actinium Pharmaceuticals, Inc. has the higher net margin (32.2% vs −241.0%) and the higher return on invested capital (0.00% vs −3,379.3%). Across the 16 metrics below, Actinium Pharmaceuticals, Inc. leads on 13 and Aligos Therapeutics, Inc. on 3.
Valuation
Profitability
| Metric | ALGS | ATNM | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 98.71% | 65.16% |
| Operating margin | (250.63%) | 27.20% | 0.00% |
| Net margin | (241.01%) | 32.18% | 0.00% |
| Free cash flow margin | (299.90%) | (66.16%) | 0.00% |
| Return on equity | (113.59%) | 45.86% | (56.36%) |
| Return on assets | (75.57%) | 21.92% | (48.04%) |
| Return on invested capital | (3,379.28%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack